HA-1004 structure
|
Common Name | HA-1004 | ||
---|---|---|---|---|
CAS Number | 91742-10-8 | Molecular Weight | 293.34 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C12H15N5O2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of HA-1004HA-1004 is a selective inhibitor of PKA, which can inhibit lipolysis and induce vascular relaxation. HA-1004 is also a dual inhibitor of cyclic GMP-dependent protein kinase and cyclic AMP-dependent protein, and is involved in smooth muscle, second messenger, cyclic AMP and cyclic GMP regulation mechanisms. HA-1004 can be used as a vasodilator to inhibit the contraction of rabbit aortic strips, or to antagonize ERK and tyrosine hydroxylase (TH) phosphorylation in morphine abstinence rat models[1][2][3]. |
Name | N-(2-((diaminomethylene)amino)ethyl)isoquinoline-5-sulfonamide |
---|
Description | HA-1004 is a selective inhibitor of PKA, which can inhibit lipolysis and induce vascular relaxation. HA-1004 is also a dual inhibitor of cyclic GMP-dependent protein kinase and cyclic AMP-dependent protein, and is involved in smooth muscle, second messenger, cyclic AMP and cyclic GMP regulation mechanisms. HA-1004 can be used as a vasodilator to inhibit the contraction of rabbit aortic strips, or to antagonize ERK and tyrosine hydroxylase (TH) phosphorylation in morphine abstinence rat models[1][2][3]. |
---|---|
Related Catalog | |
Target |
cyclic GMP-dependent protein kinase, cyclic AMP-dependent protein[2] |
References |
Molecular Formula | C12H15N5O2S |
---|---|
Molecular Weight | 293.34 |
Exact Mass | 293.09500 |
PSA | 131.84000 |
LogP | 2.65880 |